Ninsun Biotech: revolutionising cancer detection through stem cell diagnostics
Ninsun Biotech is a company that has just moved into the BioArk in Monthey and joined the Ark Foundation’s incubator.
CDMO Valsynthese is growing well in Gamsen!
For more than four decades, the SSE Group has also been a successful player in the chemical and pharmaceutical sector through its Valsynthese business unit.
Valais start-up Precise Health wins CHF 40,000 Venture Kick prize
Precise Health, a biotech start-up based at the Energypolis Campus in Sion, has won phase 2 of the national Venture Kick competition.
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
Siegfried selected the canton of Valais for its new global R&D center due to its strategic importance within the company’s network.
Haut-Valais SME ten23 health opens a new, cutting-edge facility in Viège
The company ten23 health has opened a new, cutting-edge facility in the town in Haut-Valais.
Valaisan SME Lugaia rides the wave of success with its niche products
Company owner Viktor Schnyder explains what makes Lugaia tick and how the company benefits from its location in the Valais.
Will start-up Curio Biotech soon mark an end to animal experiments?
Curio Biotech, a young firm based in the BioArk in Visp, uses human tissue to test cosmetics and medicines.
The remarkable chemical-pharmaceutical industry in the canton of Valais
For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation with economic growth.
Siegfried, a Swiss leader taking innovations to industrial scale for the pharmaceutical industry
Siegfried’s success in Evionnaz is largely attributed to the expertise and flexibility of its workforce.
Debiopharm invests CHF 30 million in Valais amidst workforce surge
Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150 to 200 in a year.